These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3524816)

  • 1. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.
    Austgulen R; Espevik T; Hammerstrøm J; Nissen-Meyer J
    Cancer Res; 1986 Sep; 46(9):4566-70. PubMed ID: 3524816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
    Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR; McKinnon KP; Koren HS
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
    Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
    Kornbluth RS; Edgington TS
    J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monocyte cytotoxic factor mediates cytolysis of WEHI 164 cells.
    Austgulen R; Hammerstrøm J; Espevik T; Nissen-Meyer J
    Cell Immunol; 1986 Mar; 98(1):211-20. PubMed ID: 3461886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytolysis of actinomycin D-treated target cells by cell-free supernatants from human monocytes.
    McKinnon KP; Chen AR; Argov S; Lane BC; Koren HS
    Immunobiology; 1986 Mar; 171(1-2):27-44. PubMed ID: 3710517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of monocyte cytotoxic factor in monocyte-mediated lysis of tumour cells.
    Espevik T; Kildahl-Andersen O; Nissen-Meyer J
    Immunology; 1986 Feb; 57(2):255-9. PubMed ID: 3081437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor in human monocyte-mediated antitumor cytotoxicity.
    Ziegler-Heitbrock HW; Thiel C; Haas JG; Möller A; Riethmüller G
    Nat Immun Cell Growth Regul; 1988; 7(5-6):280-6. PubMed ID: 3221906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of tumour necrosis factor in monocyte-mediated rapid killing of actinomycin D-pretreated WEHI 164 sarcoma cells.
    Bersani L; Colotta F; Mantovani A
    Immunology; 1986 Oct; 59(2):323-5. PubMed ID: 3770807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Production and function of the monocyte cytotoxic factor (MCF)].
    Uchida A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2098-104. PubMed ID: 2440386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antisera against recombinant tumor necrosis factor and the monocyte-derived cytotoxin(s) on monocyte-mediated killing of various tumor cells.
    Nissen-Meyer J; Espevik T
    Cell Immunol; 1987 Oct; 109(2):384-96. PubMed ID: 3478143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of monocyte cytotoxic factor (CF) in cytostasis mediated by IFN-gamma-activated monocytes.
    Kildahl-Andersen O; Nissen-Meyer J
    Immunology; 1985 Oct; 56(2):367-72. PubMed ID: 3932193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effector function of B lymphoblasts.
    Bersani L; Colotta F; Peri G; Mantovani A
    J Immunol; 1987 Jul; 139(2):645-8. PubMed ID: 3496385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-mediated drug-dependent cellular cytotoxicity: effects on different WEHI 164 target cell lines.
    Austgulen R; Kildahl-Andersen O; Espevik T
    Cancer Immunol Immunother; 1986; 22(3):176-80. PubMed ID: 3731202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
    Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
    Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.
    Espevik T; Nissen-Meyer J
    J Immunol Methods; 1986 Dec; 95(1):99-105. PubMed ID: 3782828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
    Nissen-Meyer J; Austgulen R; Espevik T
    Cancer Res; 1987 May; 47(9):2251-8. PubMed ID: 3567918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.